Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 30;78(10):1001–1011. doi: 10.1016/j.jacc.2021.07.003

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Central Illustration — Metoprolol Repurposing for Treating ARDS in Critically Ill COVID-19 Patients

Reduced lung inflammation was associated with a significant improvement in oxygenation and fewer days on mechanical ventilation and of intensive care unit admission. Repurposing metoprolol for the treatment of acute respiratory distress syndrome associated with coronavirus disease-2019 (COVID-19) appears to be a safe and inexpensive strategy that can alleviate the burden of the COVID-19 pandemic.